Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous granulomata complicating desensitization.

R A Wakeel1, M I White

  • 1Department of Dermatology, Aberdeen Royal Infirmary, Forresterhill, UK.

Clinical and Experimental Dermatology
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physical Activity and Exercise Interventions in the Workplace Impacting Work Outcomes: A Stakeholder-Centered Best Evidence Synthesis of Systematic Reviews.

The international journal of occupational and environmental medicine·2016
Same author

Mental Health Interventions in the Workplace and Work Outcomes: A Best-Evidence Synthesis of Systematic Reviews.

The international journal of occupational and environmental medicine·2016
Same author

Social Support and Supervisory Quality Interventions in the Workplace: A Stakeholder-Centered Best-Evidence Synthesis of Systematic Reviews on Work Outcomes.

The international journal of occupational and environmental medicine·2015
Same author

Job demand and control interventions: a stakeholder-centered best-evidence synthesis of systematic reviews on workplace disability.

The international journal of occupational and environmental medicine·2015
Same author

Navigating the health care system: perceptions of patients with chronic pain.

Chronic diseases in Canada·2009
Same author

Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland.

The British journal of dermatology·2005
Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026
Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026
Same journal

Dermatopathology.

Clinical and experimental dermatology·2026
Same journal

Persistent Bilateral Palmar Hyperkeratotic Papules in an Adolescent Male.

Clinical and experimental dermatology·2026
Same journal

Shuddering Attacks in an Infant Treated with Atenolol for Infantile Hemangioma: A Previously Unreported Adverse Effect.

Clinical and experimental dermatology·2026
Same journal

Male genital fixed drug eruption: a systematic review.

Clinical and experimental dermatology·2026
See all related articles

Subcutaneous granulomata developed 12 years after desensitizing injections with D-VAC Pollens, a now-withdrawn depot pollen vaccine. This case highlights potential long-term adverse effects of older immunotherapy products.

Area of Science:

  • Immunology
  • Dermatology
  • Allergy and Clinical Immunology

Background:

  • D-VAC Pollens (Bencard) was a standard depot pollen vaccine used for desensitization.
  • The product was withdrawn from the market in the mid-1970s.
  • Long-term adverse effects of older vaccine formulations are not always well-documented.

Observation:

  • A case study is presented involving a patient who received desensitizing injections of D-VAC Pollens.
  • The patient developed subcutaneous granulomata.
  • These granulomata appeared 12 years after the immunotherapy injections were administered.

Findings:

  • Delayed-onset subcutaneous granulomata can occur years after treatment with depot pollen vaccines.
  • The findings suggest a potential for persistent inflammatory reactions to vaccine components.

Related Experiment Videos

  • This case underscores the importance of long-term patient monitoring after immunotherapy.

    • Implications:

    • Clinicians should be aware of the possibility of late-developing adverse reactions to older vaccine products.
    • The case may inform future vaccine development and safety protocols.
    • Further research into the immunopathogenesis of delayed granuloma formation is warranted.